RESEARCH CENTER

Qingdao Eastsea Pharmaceutical Co., Ltd. is Qingdao Probiotic Engineering Technology Research Center,also is sole China probiotic manufacturing enterprise to have R&D ability of probiotic products.

Awarding Ceremony

Qingdao Probiotic Engineering Technology Research Center

Research center

Real-time quantitative fluorescence PCR instrument

 



R&D achievements

 

 

Qingdao Eastsea Pharmaceutical Co., Ltd takes possession of 32 China and the United States patents, which ensures exclusive rights of the production and marketing for a long time of 20 years, no matter in China market or the United States Market.

 

 

China Patent of Bacillus coagulans -A treatment for ulcerative colitis

China patent of Clostridium butyricum- a treatment for preventing smelly toxin related symptoms and diseases

The United States Patent— Composition and method for reducing feces toxins and treating digestive disorders

Clostridium butyricum- The defenders of intestinal health